arrow
S

Samy Ammari

gustave roussy
H指数:40
被引数:9,034

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Liquid biopsy tumour fraction, total tumour volume, and automated whole-body CT body composition for survival stratification in metastatic cancer: a temporally validated pan-cancer cohort study

液体活检肿瘤分数、总肿瘤体积及自动化全身CT体成分分析在转移性癌症生存分层中的应用:一项经时间验证的泛癌种队列研究

2026-09-250
PRE
Deep learning-driven incidental detection of vertebral fractures in cancer patients: advancing diagnostic precision and clinical management

基于深度学习的癌症患者椎体骨折偶然检测:提高诊断精度和临床管理

2025-08-020
OAAI
The correlation of liquid biopsy genomic data to radiomics in colon, pancreatic, lung and prostatic cancer patients

液体活检基因组数据与结直肠癌、胰腺癌、肺癌和前列腺癌患者影像组学之间的相关性

2025-07-080
PRE
Predictive factors of FOLFIRINOX chemotherapy toxicity in pancreatic adenocarcinoma patients

胰腺癌患者FOLFIRINOX化疗毒性的预测因素

2025-02-090
PRE
Trifluridine/tipiracil plus oxaliplatin ± nivolumab vs FOLFOX ± nivolumab in HER2 negative advanced oesogastric adenocarcinoma: The PRODIGE73-UCGI40-LOGICAN trial
2024-08-010
OAAI
Theragnostic Gadolinium-Based Nanoparticles Safely Augment X-ray Radiation Effects in Patients with Cervical Cancer
2024-06-244
PRE
Subcutaneous fat mass predicts progression-free survival in patients treated with antibody-drug-conjugates in early-phase clinical trials
2024-03-220
PRE
Original Research Immunosuppressant mycophenolate mofetil for patients with steroid-refractory immune-related hepatitis induced by checkpoint inhibitors in oncology

免疫抑制剂霉酚酸酯治疗免疫检查点抑制剂诱导的激素难治性免疫相关性肝炎的原创研究

2023-11-018
PRE
Predicting overall survival of patients with melanoma and NSCLC treated with immunotherapy using AI combining total tumor volume and tumor heterogeneity on CT-Scans

使用AI结合ct扫描上的总肿瘤体积和肿瘤异质性预测接受免疫治疗的黑色素瘤和非小细胞肺癌患者的总体生存率

2023-10-010
OAAI